PapalPower
- 19 May 2005 11:34




Main Web Site : www.henderson-morley.com
On line shop web site :
http://www.herpesexpert.com (Frost and Simpson)
Investor Relations email : investors@henderson-morley.com
Henderson Morley is a drug discovery company
The company has been developed specifically to carry out preliminary sourcing and screening of candidates to combat diseases caused by the herpes family of viruses and certain other DNA viruses
Latest GECR update 15th October 2006
Latest GE&CR update - 15th Oct 2006 :
The news investors have all been waiting for - regarding negotiations with a US dermatological pharmaceutical firm has finally been unveiled. The licence has been granted under an agreement to
Cutanea, a U.S. pharmaceutical company, specialising in the development of dermatology products in the US market.
The licence is for new applications of ICVT for the treatment of dermatological conditions in humans. The agreement and takes the form of an exclusive American, Mexican and Canadian wide licence to bring products to market through a programme of pre-clinical and clinical development of treatments either by Cutanea or through a sub-licence. Under the terms of the Agreement, Henderson Morley will receive up to 6.675 million dollars in development and commercialisation milestone payments up to the point at which the application receives regulatory approval, and will receive royalties on net sales thereafter.
Under its business plan, Henderson Morley has stated its belief that, following clinical development and regulatory licence approval, sales of the product in excess of $1.5 billion could be achieved over the subsequent ten year period. This would give a potential royalty to Henderson Morley in excess of $115 million over this term.
As a drug discovery company, it is imperative that Henderson continues to grant licenses to further develop its technology portfolio. This is the group's third ICVT license agreement. Encouragingly, Cutanea has a great management team with a proven track record of commercialising dermatology products.
Meanwhile, the company has announced that it has been working away on a vaccine against Koi Carp Herpes virus. The group believes it is now ready to start field trials of a
candidate vaccine, in a collaboration with the Internationally renowned Hagerman
Aquaculture Research Institute in Idaho USA. The initial immunogenicity studies should produce results within 6 months, enabling Henderson Morley scientists to optimise the vaccine formulation, with a view to securing a product licence from the veterinary authorities as soon as practicable.
Clearly activity at Henderson Morley has been significant in recent weeks. The licensing announcement is very encouraging, but with the news now out of the way, the shares have eased - a classic case of buy on the rumour, sell on the news. That said, the stock has now pulled back below the recent placing price. With so much going on at the company, further newsflow in the shorter term is far from unlikely.
*Henderson Morley is a corporate client of Bishopsgate Communications which is owned by RSH, the ultimate owner of GE&CR.
Forecasts and a formal recommendation are suspended ahead of the publication of a detailed note next month.
kkeith2000
- 03 Jul 2007 07:50
- 240 of 296
This is going to fly now
Waited a long time for this
kkeith2000
- 03 Jul 2007 12:39
- 241 of 296
After a near 40% rise in the blink of an eye dropped back down a bit to 16% now
Reading the RNS it looks like the company is trying to force someones hand who as been stakebuilding
Active
- 03 Jul 2007 18:24
- 242 of 296
I've made my maiden purchase today at 2.76 pence. I think just on speculation we are set for the next wave off rises with HML. I would expect the price to get to nearer to 4 pence in the next few days before anyone shows their hand!
kkeith2000
- 03 Jul 2007 19:47
- 243 of 296
I would think so as well. The directors bought a few at 2.5 i think so they would want a fair price
Am hoping tomorrow some press coverage may throw some light on things
kkeith2000
- 11 Jul 2007 10:56
- 244 of 296
A new website but can't find anything on Koi Herpes vaccine
cynic
- 11 Jul 2007 11:27
- 245 of 296
didn't know that goldfish went in for oral sex so much that herpes would give them concern ...... do they also get genital warts which are a closely related virus?
Marcel1970
- 09 Aug 2007 16:33
- 246 of 296
HML Anyone know when the next update is due, its now lower than it was before the last RNS. Anyone any thoughts?
banjomick
- 05 Nov 2007 22:26
- 247 of 296
Looking like sentiment is changing but a bit early to say if HML can stay above 2p and move forward.AGM 14th November 2007 which may have some bearing on recent volume.Only have a relatively small amount of these from a few months ago so haven't looked in any great detail.Interesting though!
banjomick
- 07 Nov 2007 09:02
- 248 of 296
Hmmmm,looking good but will it last?
cynic
- 07 Nov 2007 09:05
- 249 of 296
why should it?
banjomick
- 07 Nov 2007 10:56
- 250 of 296
exactly but then again why not? :-)
All depends on news as always...............
moneyplus
- 07 Nov 2007 11:18
- 251 of 296
Maybe the long rumoured bid is just around the corner--it's certainly perking up!!
holly12345
- 20 Dec 2007 13:02
- 252 of 296
hi all
kkeith2000
- 20 Dec 2007 14:18
- 253 of 296
Hi holly not much action on here am afraid, am still holding these in the hope they may deliver something but it's a long painful wait
Some news on the ICVT should be due soon according to a RNS on the 20 June 2007, but don't hold your breath -)
RNS Number:6594Y
Henderson Morley PLC
20 June 2007
"It is envisaged that a final injectable formulation of ICVT will be ready
for Pre-IND discussions with the FDA by December 2007"
holly12345
- 21 Dec 2007 14:59
- 254 of 296
kkeith, its the Koi deal that everyones waiting for then 6/8p minimum which could come anyday.
Good luck.
cynic
- 21 Dec 2007 16:56
- 255 of 296
is not SEO are better bet?
oilivergas
- 10 Jan 2008 19:11
- 256 of 296
Brief research, though my weekend will be spent working on this suggests this could very well be highly lucrative solution if the KHV cure can be brought to market. These koi cost tens of thousands pounds each, the owner of the KOI farms would pay handsome rewards.
http://www.digitallook.com/news/rns/1038498-14431/HML-Scientific_Programme_Update.html
Could any person answer this simple question, are any other companies closer to bringing a cure to market than HML?
A simple search using the word KHV shows the devastation this disease causes. What a silly comment SEO are better. Like comparing a rover with a BMW. I enjoy finding these little penny stocks, I have massive concerns about those 3p spikes tones of ramping; I really hope that is not the case.
Good stuff
holly12345
- 24 Jan 2008 09:12
- 257 of 296
Olivergas, none what so ever. See Thefruits comments over on the ADVFN BB.
oilivergas
- 24 Jan 2008 09:43
- 258 of 296
holly12345 thanks if you do a check he has flipped. i never believe what I read on BB's good for finding places to dig. I currently hold FRR, fweb, SEG and just bought some OHM. I think I will move a few K into HML. These penny stocks bring out the kid in me.
holly12345
- 24 Jan 2008 12:45
- 259 of 296
Oilivergas, TF knows more about HML than they do he's no ramper either.
KHV due any day now along with a certain Mr Dunne picking up a few more millions this year watch for largish buys coming in, you could catch it before the spike which this time around will not fall days after.